FDA weight loss drugs

Stimulants:

Amphetamines:

Amphetamines such as Adderall, Adderall XR, Dextroamphetamine and Mydasis are stimulates which can help people with ADHD. Some people use amphetamines for weight loss or to boost energy and alertness. High doeses can cause a rise in body temperature, irregular heartbeat and even cardiac arrest. Nicknames for amphetamines include “speed”, “black beauties” or “bennies”. 

Methyphenidate: is a stimulate in ADHD drugs such as Concerta, Daytrana, Metadate, Methylin and Rtalin. 

FDA Approved Medicines for weight loss

Contrave: (AKA/ naltrexone/Bupropion): Nalpropion Pharmaceuticals, Inc. holds New Drug application No. 200063 for and markets Contrave for weight management in overweight or abese adults. Nalpropion also holds three patents: US Patents No: 7,462,626 drawn to a method for treating overweight or obesity by adminsitering bupropion in an amount effective to induce weight and adminsitering naltrexone in an amount effective to enhance the weight lowss activity of buropion. However, these patents were held to be invalid for obviousness given the prior art literature below. The court holding that the combination of the drugs could not have been unexpected given that the combination of the two drugs was already known and that both drugs were understood to be useful for the purpose of inducing weight loss. 

O’Malley (US Patent No: 6,541,478) entitled “Smoking Cessation Treatment Using Naltrexone and Related Compounds” discloses that weight gain is a significant problem with smoking cessation and that the use of opinoid antagnonist, including naltrexone, alone or with other withdrawal attenuating agents minimizes weight gain during treatment. 

Jain “Bupropion SR vs. Pacebo for weigth loss in obese patients with depressive symptoms” 10 Obesity Res. 1049-56 (2002), J.A. 7171-78) discloses that studies suggest that bupropion SR is also effective for weight loss)

Atkinson (“Bupropian SR Enhances Weight Loss: A 48-week double-blind, placebo-controlled trial, 10 Obesity Res. 633-41 (2002), J.A. 7160-68) discloses a small but significant weight loss in women but no significant effect in mean with long-term naltrexone administration. 

Dante (US Patent no: 5,817,665) discloses that a woman in her thirites who was started on naltrexone without making any other changes rapidly lost her craving for sweets and lost thrity pounds in three weeks. 

Using Bacteria to Control Weight Loss

Arla Foods amda, the largest producer of dairy produces in Scandanavia, has patnet 9,113,641 which relates to a composition of L. paracasei and a milk product used to regulate fat uptake. 

Jiinis Biopharmaceuticals has a patent directed to mutagenized L. acidophilus strains. 

Nestec S.A. has a number of patents relacting to formulations of lactic acid bcteria used to prevent weight gain. Patent Nos. 8,318,150, 8318,151 describe the use of two strains of the same probiotic species, Lactobacillus rhamnosus whereas Patent No. 8,440, 178 describes the use of two additional L. rhamnosus strains and Patent No. 8,454,949 related to the use of similar probiotic species, L. helveticus. Another patent 9,101,651 is for the use of probiotic L. rhamosus strain.  

Foods for Weight Loss: 

The benefits of a diet rich in fruits, vegetables, legumes, nuts and whole grains is hard to dispute. Combined with exercise, an ideal body weight and a bit of alcohol, that kind of diet is your best bet against chronic ill health.

Other ways to deliver Nutraceuticals

Chewing Gum:

Fertin Pharma has weight loss products in the form of chewing gum. 

Micro-Laser

Sono-Bello 

Send an Email. All fields with an * are required.